Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on 68Ga-FAPI-46 for Imaging in Patients with Non-Metastatic Pancreatic Cancer

    Recruiting

    1 1 1
    Investigated Diseases:
    France
  • Study of immune response and biomarkers in patients with metastatic solid tumors treated with BMS-986340 and nivolumab

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    Italy
  • Efficacy and Safety of SIL204 Combined with Standard Chemotherapy in Patients with Locally Advanced Pancreatic Cancer

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    Germany
  • Study of Gemcitabine with Paclitaxel versus Standard Chemotherapy Combination for Patients with Borderline Resectable Pancreatic Cancer Based on Gene Analysis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    France
  • Study on the Safety and Effectiveness of mFOLFIRINOX with or without BNT321 for Patients with Resected Pancreatic Cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    Denmark France Germany Spain
  • A Study of Saruparib for Patients with Metastatic Pancreatic Cancer with Homologous Repair Deficiency as First Treatment

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of AZD4360 safety and effectiveness in adults with advanced solid tumors including gastric, gastroesophageal junction, biliary tract cancer and pancreatic cancer

    Not recruiting

    2 1 1
    Investigated Drugs:
    Germany
  • Study on the Safety and Effectiveness of AZD0022 Alone and with Other Cancer Drugs for Adults with KRAS-G12D Mutated Tumors in Lung, Colorectal, and Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium Italy The Netherlands Poland Spain
  • Study on Survival in Patients with Resectable Pancreatic Cancer Using Irinotecan, Fluorouracil, Calcium Folinate, and Oxaliplatin Combination Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    France Germany Italy Spain